Dr. Schafer Appointed to Director of the Richard T. Silver, MD, Myeloproliferative Neoplasm Center
Dr. Andrew I. Schafer
Dr. Andrew I. Schafer, Professor of Medicine and former Chair of the department, has been named as Director of the Richard T. Silver, MD, Myeloproliferative Neoplasm Center. A ceremony was held in February to dedicate the new center, which will further translational research and treatments in the field of myeloproliferative neoplasms (MPNs).
Dr. Schafer is an expert in the research and treatment of MPNs and a world-renowned physician-scientist in hematology and medical oncology. As Director of the Richard T. Silver, MD, Myeloproliferative Neoplasm Center, he will manage both the biomedical research and clinical activities surrounding MPNs. He will engage a team of interdisciplinary translational scientists to study the molecular underpinnings of these diseases and their application to patient care in cutting-edge clinical trials. He is also overseeing the assembly of an outstanding team of clinician specialist experts within and beyond the Department of Medicine in order to provide exceptional, comprehensive evaluations and management of patients with MPNs and their complications. The research and clinical arms of the Center will be completely integrated, with the goal of becoming one of the world’s leading Centers for the study and care of MPNs. Dr. Schafer stated that he has a “very deep appreciation of the challenges these diseases pose and the progress that needs to be.”
A member of the Institute of Medicine (IOM) of the National Academy of Sciences, Dr. Schafer is a former President of the American Society of Hematology and the Association of Professors of Medicine, and is actively conducting basic research into mechanisms of thrombosis in the MPNs with colleagues in the Department of Bioengineering at Cornell University in Ithaca, where he also holds an Adjunct Professor appointment.